Eurekalert

Subscribe to Eurekalert feed Eurekalert
The premier online source for science news since 1996. A service of the American Association for the Advancement of Science.
Updated: 3 years 1 month ago

A LiDAR device the size of a finger available

May 16 2021 - 00:05
POSTECH research team led by Junsuk Rho presents a nanophotonics-based ultracompact LiDAR technology in a world-renowned journal.
Categories: Content

Future sparkles for diamond-based quantum technology

May 16 2021 - 00:05
Two research breakthroughs are poised to accelerate the development of synthetic diamond-based quantum technology.
Categories: Content

Sperm help 'persuade' the female to accept pregnancy

May 16 2021 - 00:05
Sperm are generally viewed as having just one action in reproduction -- to fertilize the female's egg - but studies at the University of Adelaide are overturning that view.
Categories: Content

No benefit to FFR-guided PCI in STEMI patients with multi-vessel disease

May 16 2021 - 00:05
In patients who had a coronary stent inserted after experiencing the most severe type of heart attack, the use of a technique that measures blood flow and pressure through a partially blocked artery to determine if a second stenting procedure is needed did not improve outcomes and was more costly than using angiography, or a heart X-ray, alone to guide the procedure, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Rivaroxaban reduces first and total ischemic events in patients with peripheral artery disease

May 16 2021 - 00:05
Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral artery disease (PAD) who underwent lower extremity revascularization, a procedure to open blocked arteries in the leg. The findings, presented at the American College of Cardiology's 70th Annual Scientific Session, expand on earlier data and underscore the broad absolute benefits of this strategy in this high-risk patient population, researchers said.
Categories: Content

Heart-protecting drugs likely unnecessary for many breast cancer patients

May 16 2021 - 00:05
Taking medications to protect the heart from damage associated with adjuvant breast cancer therapy--medications that are administered in addition to surgery to remove a tumor--did not significantly improve markers of heart health two years after breast cancer treatment, according to a study presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Tailored cardiac rehab program improves function and quality of life in older heart failure patients

May 16 2021 - 00:05
Older patients hospitalized with acute heart failure who participated in a novel 12-week physical rehabilitation (rehab) program tailored to address their specific physical impairments had significant gains not only in physical functioning but also quality of life and depression compared with those receiving usual care, regardless of their heart's ejection fraction, according to a new study presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Dapagliflozin did not significantly reduce organ failure or death in high-risk patients hospitalized

May 16 2021 - 00:05
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing serious complications compared to placebo, according to data presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Higher blood levels of omega-3 fatty acids from prescription fish oil showed no effect on CV events

May 16 2021 - 00:05
Patients at high risk for cardiovascular events who had the highest levels of eicosapentaenoic acid (EPA) in their blood one year after taking daily omega-3 carboxylic acid, a prescription-grade fish oil, had similar rates of major cardiovascular events as people taking a corn oil placebo, according to a secondary analysis of the STRENGTH trial presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Evinacumab could help some patients with severe hypertriglyceridemia

May 16 2021 - 00:05
People with extremely high levels of triglycerides (a type of fat in the blood) and a specific genetic profile saw a substantial reduction in triglycerides after taking the human monoclonal antibody evinacumab compared with those taking a placebo, in a study presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

De-escalation of dual antiplatelet therapy appears safe and effective

May 16 2021 - 00:05
Among patients who had a cardiac stent inserted after a heart attack, switching to less-potent dual antiplatelet therapy (DAPT) after 30 days was safer and more effective in preventing adverse events a year later than continuing on a high-potency DAPT regimen, according to data presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

No improvement in outcomes with rapid, high-sensitivity troponin T testing protocol at one year

May 16 2021 - 00:05
Using more sensitive and frequent repeat testing of a blood test that indicates heart injury to guide the treatment of low-risk patients with symptoms of a possible heart attack resulted in patients being discharged earlier and receiving fewer cardiac stress tests but did not improve patient outcomes after one year, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Clopidogrel superior to aspirin for long-term post-stent maintenance

May 16 2021 - 00:05
Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse events after one year of dual antiplatelet therapy (DAPT) following the insertion of a coronary stent, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Burnout rates double for cardiology clinicians amid COVID-19

May 16 2021 - 00:05
The coronavirus pandemic has upended nearly every aspect of everyday life and continues to have devastating effects worldwide. It has also taken a significant toll on cardiovascular clinicians, many of whom provide direct care to patients with COVID-19, according to results of a new survey presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Renal denervation lowers blood pressure in medication-resistant hypertension

May 16 2021 - 00:05
Two months after undergoing renal denervation (RDN), patients with high blood pressure who did not respond to treatment with multiple medications had a greater reduction in daytime systolic blood pressure than patients who did not receive RDN, with no difference in major adverse effects, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Categories: Content

Study shows online gambling soared during lockdown, especially among regular gamblers

May 16 2021 - 00:05
Regular gamblers were more than six times more likely to gamble online compared to before the COVID-19 pandemic, according to new research.
Categories: Content

Middle-aged women urged to check their blood pressure to avoid heart attacks

May 16 2021 - 00:05
Women with mildly elevated blood pressure in their early 40s have a two-fold risk of acute coronary syndromes in their 50s compared to their counterparts with normal blood pressure. That's the finding of a study published on World Hypertension Day in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).
Categories: Content

The Lancet: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030

May 16 2021 - 00:05
In the first-ever global report on cardiovascular disease (CVD) in women, researchers call for urgent action to improve care and prevention, fill knowledge gaps, and increase awareness to tackle the worldwide leading cause of death among women. The all female-led Commission report was published in The Lancet and presented during a plenary session at the American College of Cardiology's 70th Annual Scientific Session (ACC.21).
Categories: Content

Mount Sinai cardiologist leads commission to help reduce burden of women's heart disease

May 16 2021 - 00:05
Group's worldwide health recommendations aim to improve outcomes by 2030.
Categories: Content

Zapping nerves with ultrasound lowers drug-resistant blood pressure

May 16 2021 - 00:05
Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.
Categories: Content